2Clinical Observation of Topotecan and Etoposide plus Cisplatin in Treating Small Cell Lung Cancer5-7
5Impact of K-ras gene mutation on neoadjuvant chemotherapy in patients with Stage ⅢA non-small cell lung cancer14-17
6Concomitant Radiochemotherapy plus Boost Radiation with Three Dimensional-conformal Radiotherapy for Locally Advanced Non-small Cell Lung Cancer18-20
7Clinical observation of irinotecan combining cisplatin on progressive non-small cell lung cancer21-22
10Treatment of Advanced Gastric Cancer with the Regimen of Oxaliplatin,Hydroxycamptothecine,Leucovorin and Fluorouracil29-31
12Clinical Study of Continuous Venous Infusion of Low-dose 5-Fluorouracil and Cisplatin for Treatment of Advanced Gastric Cancer35-37
13The Clinical Observation of Oxalipclatin (L-OHP) Combined with Hydroxycamptothecine (HCPT) for the patients with Refractory Advanced Colorectal Cancer38-40
14The Effect of Ondansetron and Azasetron was Compared in Prevention of Nausea and Vomiting Induced by Anti-Cancer Drugs41-43
15The clinical significance of the expression of urokinase type plasminogen activator and plasminogen activator inhabitor in thyroid carcinomas44-47
17The value of neoadjuvant chemotherapy in the treatment of medium or terminal stage of nasopharyngeal carcinoma52-54
18The Clinical Analysis on 192 Cases with Malignant Pleural Celiac Effusion Treated by biochemotherapy55-57
